Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Sarcomeric proteins and inherited cardiomyopathies

Sarcomeric proteins and inherited cardiomyopathies Over the last two decades, a large number of mutations have been identified in sarcomeric proteins as a cause of hypertrophic, dilated or restrictive cardiomyopathy. Functional analyses of mutant proteins in vitro have revealed several important functional changes in sarcomeric proteins that might be primarily involved in the pathogenesis of each cardiomyopathy. Creation of transgenic or knock-in animals expressing mutant proteins in their hearts confirmed that these mutations in genes for sarcomeric proteins induced distinct types of cardiomyopathies and provided useful animal models to explore the molecular pathogenic mechanisms and potential therapeutics of cardiomyopathy in vivo. In this review, I discuss the functional consequences of mutations in different sarcomeric proteins found in hypertrophic, dilated, and restrictive cardiomyopathies in conjunction with their effects on cardiac structure and function in vivo and their possible molecular and cellular mechanisms, which underlie the pathogenesis of these inherited cardiomyopathies. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Cardiovascular Research Oxford University Press

Sarcomeric proteins and inherited cardiomyopathies

Cardiovascular Research , Volume 77 (4) – Mar 1, 2008

Loading next page...
 
/lp/oxford-university-press/sarcomeric-proteins-and-inherited-cardiomyopathies-7vBkiWWTsW

References (105)

Publisher
Oxford University Press
Copyright
© Published by Oxford University Press.
Subject
REVIEWS: FOCUS ON THE CARDIAC SARCOMERE
ISSN
0008-6363
eISSN
1755-3245
DOI
10.1093/cvr/cvm084
pmid
18056765
Publisher site
See Article on Publisher Site

Abstract

Over the last two decades, a large number of mutations have been identified in sarcomeric proteins as a cause of hypertrophic, dilated or restrictive cardiomyopathy. Functional analyses of mutant proteins in vitro have revealed several important functional changes in sarcomeric proteins that might be primarily involved in the pathogenesis of each cardiomyopathy. Creation of transgenic or knock-in animals expressing mutant proteins in their hearts confirmed that these mutations in genes for sarcomeric proteins induced distinct types of cardiomyopathies and provided useful animal models to explore the molecular pathogenic mechanisms and potential therapeutics of cardiomyopathy in vivo. In this review, I discuss the functional consequences of mutations in different sarcomeric proteins found in hypertrophic, dilated, and restrictive cardiomyopathies in conjunction with their effects on cardiac structure and function in vivo and their possible molecular and cellular mechanisms, which underlie the pathogenesis of these inherited cardiomyopathies.

Journal

Cardiovascular ResearchOxford University Press

Published: Mar 1, 2008

Keywords: Sarcomere Gene mutation Hypertrophic cardiomyopathy Dilated cardiomyopathy Restricted cardiomyopathy

There are no references for this article.